Initial monotherapy and combination therapy and hypertension control the first year.

Hypertension
Brent M EganKristina S Yu-Isenberg

Abstract

Initial antihypertensive therapy with single-pill combinations produced more rapid blood pressure control than initial monotherapy in clinical trials. Other studies reported better cardiovascular outcomes in patients achieving lower blood pressure during the first treatment year. We assessed the effectiveness of initial antihypertensive monotherapy, free combinations, and single-pill combinations in controlling untreated, uncontrolled hypertensives during their first treatment year. Electronic record data were obtained from 180 practice sites; 106 621 hypertensive patients seen from January 2004 to June 2009 had uncontrolled blood pressure, were untreated for ≥ 6 months before therapy, and had ≥ 1 one-year follow-up blood pressure data. Control was determined by the first follow-up visit with blood pressure <140/<90 mm Hg for patients without diabetes mellitus or chronic kidney disease and <130/<80 mm Hg for patients with either or both conditions. Multivariable hazards regression ratios (HRs) and 95% CIs for time to control were calculated, adjusting for age, sex, baseline blood pressure, body mass index, diabetes mellitus, chronic kidney disease, cardiovascular disease, initial therapy, final blood pressure medication number,...Continue Reading

References

May 1, 1996·Journal of the American Medical Informatics Association : JAMIA·M M Wagner, W R Hogan
Jun 27, 2003·The Journal of Clinical Hypertension·George L BakrisUNKNOWN Study of Hypertension and the Efficacy of Lotrel in Diabetes (SHIELD) Investigators
Sep 25, 2003·JAMA : the Journal of the American Medical Association·Sean R TunisCarolyn M Clancy
Dec 6, 2003·Hypertension·Aram V ChobanianUNKNOWN National High Blood Pressure Education Program Coordinating Committee
Jan 25, 2006·The American Journal of Medicine·Hayden B BosworthEugene Z Oddone
Aug 7, 2007·The American Journal of Medicine·Sripal BangaloreFranz H Messerli
Dec 5, 2008·The New England Journal of Medicine·Kenneth JamersonUNKNOWN ACCOMPLISH Trial Investigators
Oct 9, 2009·Quality & Safety in Health Care·C L NassarallaS M Tulledge-Scheitel
Jan 1, 2010·Therapeutic Advances in Cardiovascular Disease·Jan Basile, Joel Neutel
Feb 26, 2010·Journal of General Internal Medicine·Susan R HeckbertMichael Von Korff
May 27, 2010·JAMA : the Journal of the American Medical Association·Brent M EganR Neal Axon
Oct 6, 2010·Hypertension·John M FlackUNKNOWN International Society on Hypertension in Blacks
May 14, 2011·American Journal of Preventive Medicine·Rodger Kessler, Russell E Glasgow

❮ Previous
Next ❯

Citations

Nov 5, 2013·American Journal of Hypertension·Teemu J NiiranenAntti M Jula
Jul 1, 2014·Quality Management in Health Care·Shannon M HudsonMarilyn A Laken
Feb 18, 2014·High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension·Massimo VolpeAthanasios J Manolis
Feb 5, 2014·High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension·Harold BaysHelmut Schumacher
Apr 5, 2013·Advances in Therapy·Manuel Gorostidi, Alejandro de la Sierra
Aug 29, 2014·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·M E Safar, J Blacher
Feb 15, 2013·Journal of Hypertension·Anna Oliveras, Roland E Schmieder
Sep 28, 2013·Expert Opinion on Pharmacotherapy·Vivencio Barrios, Carlos Escobar
Sep 18, 2012·Current Medical Research and Opinion·Sverre E KjeldsenLisheng Liu
May 20, 2014·Current Medical Research and Opinion·Steen NeldamJoel M Neutel
Feb 25, 2015·Current Medical Research and Opinion·Abdul Rashid Abdul RahmanBrian Tomlinson
Dec 31, 2014·Journal of the Chinese Medical Association : JCMA·Chern-En ChiangShing-Jong Lin
Feb 14, 2013·Primary Care·Katherine H WinterAnthony J Viera
Jun 5, 2013·The Journal of Clinical Hypertension·William J ElliottTorry M Sansone
Aug 21, 2013·International Journal of Clinical Practice·S NeldamH Schumacher
Aug 13, 2014·Journal of the American Geriatrics Society·Xiaojuan LiMichele Jonsson Funk
Apr 3, 2015·Lancet·Neil R PoulterMark Caulfield
Mar 11, 2015·Current Hypertension Reports·Keith C Ferdinand, Samar A Nasser
Jan 16, 2015·Journal of Cardiovascular Medicine·Claudio BorghiArrigo F G Cicero
Dec 10, 2013·Medicina clínica·Alejandro de la SierraUNKNOWN los investigadores del estudio COMBICONTROL
May 12, 2016·Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·D ProchnauR Surber
Aug 9, 2016·Expert Review of Clinical Pharmacology·Stewart B Harris
Nov 30, 2016·Journal of Hypertension·Giuseppe ManciaGiovanni Corrao
Feb 20, 2018·The Journal of Clinical Hypertension·Luis M Ruilope, Jose R Banegas
Oct 31, 2017·Current Cardiology Reports·Nomsa Musemwa, Crystal A Gadegbeku
Aug 10, 2018·Expert Review of Clinical Pharmacology·Manuel Gorostidi, Alejandro de la Sierra
Sep 4, 2018·Journal of the Renin-angiotensin-aldosterone System : JRAAS·Michael A WeberCharlie Cao
Nov 21, 2017·Journal of the American Heart Association·Thomas M MacDonaldUNKNOWN British Hypertension Society Programme of Prevention And Treatment of Hypertension With Algorithm‐based Therapy (PATHWAY)
Apr 19, 2013·Hypertension·James R Sowers

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.